During the past decade, Samodzielny Publiczny Szpital Kliniczny Nr 1 conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 15 clinical trials were completed, i.e. on average, 39.5% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 11 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Samodzielny Publiczny Szpital Kliniczny Nr 1" #1 sponsor was "Incyte Corporation" with 4 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Gilead Sciences" with 3 trials sponsored and "Amgen" with 3 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Samodzielny Publiczny Szpital Kliniczny Nr 1" #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator, "Chugai Pharmaceutical" with 2 trials as a collaborator, "Pharmacyclics LLC." with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Samodzielny Publiczny Szpital Kliniczny Nr 1" are "Atopic Dermatitis" (3 trials), "Primary Myelofibrosis" (3 trials), "Abdominal Aortic Aneurysm" (2 trials), "Cervical Dysplasia" (2 trials) and "Cervical High Grade Squamous Intraepithelial Lesion" (2 trials). Many other conditions were trialed in "Samodzielny Publiczny Szpital Kliniczny Nr 1" in a lesser frequency.

Most popular intervention types in "Samodzielny Publiczny Szpital Kliniczny Nr 1" are "Drug" (36 trials), "Biological" (11 trials), "Device" (8 trials), "Other" (7 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Lebrikizumab" (3 trials), "Rituximab" (3 trials), "placebo" (3 trials) and "Azacitidine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Samodzielny Publiczny Szpital Kliniczny Nr 1" are 44 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Samodzielny Publiczny Szpital Kliniczny Nr 1". undefined are not yet recruiting, 11 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Samodzielny Publiczny Szpital Kliniczny Nr 1, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Samodzielny Publiczny Szpital Kliniczny Nr 1, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Samodzielny Publiczny Szpital Kliniczny Nr 1 has several departments that took part in Clinical trials: "Klinika Chirurgii Onkologicznej" - 6 trials, "Samodzielny Publiczny Szpital Kliniczny Nr 1 w Lublinie Klinika Ginekologii Onkologicznej i Ginekologii" - 2 trials